Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Kehoe

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2021
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screeningShengqing Gu, Stephanie Lheureux, Azin Sayad, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2024
Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancerFong Lien Audrey Kwong, Caroline Kristunas, Clare Davenport, et al.
BMJ Open|August 11, 2016
Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancerSudha Sundar, Caroline Rick, Francis Dowling, et al.
Cancers|February 25, 2023
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UKSamuel Oxley, Ashwin Kalra, Michail Sideris, et al.
The Lancet. Oncology|October 3, 2024
Risk-prediction models in postmenopausal patients with symptoms of suspected ovarian cancer in the UK (ROCkeTS): a multicentre, prospective diagnostic accuracy studySudha Sundar, Ridhi Agarwal, Clare Davenport, et al.
The Lancet. Oncology|November 11, 2018
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trialsIgnace Vergote, Corneel Coens, Matthew Nankivell, et al.
Gynecologic Oncology|April 22, 2019
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumorMartin Gore, Allan Hackshaw, William E Brady, et al.
BMJ (Clinical Research Ed.)|January 28, 2026
Diagnostic tests for ovarian cancer in premenopausal women with non-specific symptoms (ROCkeTS): prospective, multicentre, cohort studySudha Sundar, Ridhi Agarwal, Katie Scandrett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Proteomic profiling identifies afamin as a potential biomarker for ovarian cancerDavid Jackson, Rachel A Craven, Richard C Hutson, et al.
Journal of Medical Ethics|September 19, 2013
Position statement on ethics, equipoise and research on charged particle radiation therapyMark Sheehan, Claire Timlin, Ken Peach, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2021
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screeningShengqing Gu, Stephanie Lheureux, Azin Sayad, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2024
Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancerFong Lien Audrey Kwong, Caroline Kristunas, Clare Davenport, et al.
BMJ Open|August 11, 2016
Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancerSudha Sundar, Caroline Rick, Francis Dowling, et al.
Cancers|February 25, 2023
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UKSamuel Oxley, Ashwin Kalra, Michail Sideris, et al.
The Lancet. Oncology|October 3, 2024
Risk-prediction models in postmenopausal patients with symptoms of suspected ovarian cancer in the UK (ROCkeTS): a multicentre, prospective diagnostic accuracy studySudha Sundar, Ridhi Agarwal, Clare Davenport, et al.
The Lancet. Oncology|November 11, 2018
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trialsIgnace Vergote, Corneel Coens, Matthew Nankivell, et al.
Gynecologic Oncology|April 22, 2019
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumorMartin Gore, Allan Hackshaw, William E Brady, et al.
BMJ (Clinical Research Ed.)|January 28, 2026
Diagnostic tests for ovarian cancer in premenopausal women with non-specific symptoms (ROCkeTS): prospective, multicentre, cohort studySudha Sundar, Ridhi Agarwal, Katie Scandrett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Proteomic profiling identifies afamin as a potential biomarker for ovarian cancerDavid Jackson, Rachel A Craven, Richard C Hutson, et al.
Journal of Medical Ethics|September 19, 2013
Position statement on ethics, equipoise and research on charged particle radiation therapyMark Sheehan, Claire Timlin, Ken Peach, et al.
Pageof 10